Intervention

XmAb20717

ClinicalTrials.gov intervention label

Clinical trials2
Recruiting0
Common conditions25
Lead sponsors shown2

Common conditions

Basal Cell Carcinoma1Breast Carcinoma1Castration-Resistant Prostate Carcinoma1Cervical Cancer1Cervical Carcinoma1Cholangiocarcinoma1Colorectal Carcinoma1Endometrial Carcinoma1Extrapulmonary High Grade1Fallopian Tube Carcinoma1Gastric or Gastroesophageal Junction Adenocarcinoma1Hepatocellular Carcinoma1Hodgkin's Lymphoma1Malignant Adnexal Neoplasms1Melanoma1Mesothelioma1Microsatellite High Cancers1Nasopharyngeal Carcinoma1Neuroendocrine Carcinoma1Neuroendocrine Carcinomas1Non-small Cell Lung Carcinoma1Non-squamous Cell Salivary Gland Carcinoma1Ovarian Carcinoma1Peritoneal Mesothelioma1Pleural Mesothelioma1

Trial status mix

COMPLETED1
SUSPENDED1

Phase mix

PHASE11
PHASE21

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.